By Counterforce Health Team in Tavalisse (fostamatinib disodium hexahydrate) —

How to Get Tavalisse (fostamatinib) Covered by Cigna in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tavalisse (fostamatinib) Covered by Cigna in New Jersey

Tavalisse (fostamatinib) requires prior authorization from Cigna and is typically covered as a specialty medication for chronic ITP after failed first-line treatments. Your fastest path to approval: 1) Have your hematologist document inadequate response to corticosteroids, IVIG, or TPO receptor agonists with current platelet counts and bleeding risk, 2) Submit prior authorization through Cigna's provider portal with complete clinical documentation, and 3) If denied, file an internal appeal within 180 days, followed by New Jersey's Independent Health Care Appeals Program (IHCAP) for external review. Start today by gathering your treatment history and current lab results.

Table of Contents

  1. Renewal Triggers: When to Start the Process
  2. Evidence Update: What Documentation You Need
  3. Renewal Packet: Must-Include Documents
  4. Timeline: Submission and Decision Windows
  5. If Coverage Lapses: Bridge Options
  6. Annual Changes: What to Re-Verify
  7. Appeals Playbook for Cigna in New Jersey
  8. Personal Tracker Template
  9. FAQ

Renewal Triggers: When to Start the Process

Cigna requires annual renewal of prior authorization for Tavalisse (fostamatinib) for chronic ITP patients. Here's when to start preparing:

Start 60-90 Days Before Expiration

  • Check your approval letter for the exact expiration date
  • Cigna typically approves Tavalisse for 12-month periods
  • Beginning the renewal process early prevents treatment interruptions

Early Warning Signs to Act Immediately

  • Pharmacy notifications about upcoming authorization expiration
  • Changes in your insurance plan or formulary status
  • New clinical developments (side effects, dosing changes, concurrent medications)
  • Upcoming transitions (job changes, Medicare enrollment, plan switches)
Tip: Set a calendar reminder 90 days before your current authorization expires. This gives you time to gather documentation and address any complications.

Evidence Update: What Documentation You Need

For Tavalisse renewal, Cigna requires specific clinical evidence demonstrating ongoing medical necessity:

Required Clinical Documentation

  • Ongoing hematologist involvement: Prescription must be from or in consultation with a hematologist
  • Demonstrated beneficial clinical response: Evidence of increased or maintained platelet counts and/or decreased bleeding episodes
  • Continued bleeding risk: Documentation showing patient remains at risk for bleeding complications from chronic ITP
  • Updated laboratory results: Current platelet counts (monthly monitoring required)
  • Treatment adherence: Minimum 85% therapy adherence unless documented interruption for surgery or infection

Response Monitoring Criteria

According to Cigna's coverage policy, patients must maintain:

  • Platelet count ≥50,000/mm³ to demonstrate therapeutic benefit
  • No concurrent use with other second-line agents (rituximab, TPO agonists, immune globulin)
  • Regular monitoring: Monthly CBC, liver function tests, and blood pressure checks

Renewal Packet: Must-Include Documents

Core Documentation Checklist

  • Current hematologist letter detailing ongoing clinical benefit
  • Updated platelet counts from the past 3 months
  • Complete blood count (CBC) with differential
  • Liver function tests (AST, ALT, bilirubin)
  • Blood pressure readings
  • Documentation of adherence to therapy
  • Summary of any adverse events or dose adjustments

Letter of Medical Necessity Structure

Your hematologist's renewal letter should include:

  1. Patient identification and chronic ITP diagnosis with ICD-10 code
  2. Prior treatment failures (corticosteroids, IVIG, TPO receptor agonists)
  3. Current clinical status with recent platelet counts and bleeding risk assessment
  4. Response to Tavalisse with specific improvements documented
  5. Ongoing monitoring plan and safety assessments
  6. Medical necessity statement for continued therapy

Timeline: Submission and Decision Windows

Standard Review Process

  • Submission: 60-90 days before current authorization expires
  • Cigna review time: Up to 15 business days for standard requests
  • Decision notification: Via provider portal, fax, or mail
  • Effective date: Typically aligns with current authorization expiration

Expedited Review Options

If you're at immediate risk for bleeding complications:

  • Expedited review: 72 hours for urgent cases
  • Required documentation: Clinical justification for urgency
  • Contact: Cigna provider services at provider portal (verify current link)

If Coverage Lapses: Bridge Options

Immediate Actions

  1. Contact Rigel OneCare at 1-833-744-3562 for temporary supply assistance
  2. File expedited appeal if denial was inappropriate
  3. Request peer-to-peer review with Cigna medical director
  4. Consider formulary exception if coverage criteria changed

Patient Assistance Resources

Rigel Pharmaceuticals offers comprehensive support through Rigel OneCare:

  • Copay assistance: Eligible patients may pay as little as $15 per prescription
  • Bridge therapy: Temporary supply during coverage gaps
  • Free drug program: For uninsured or underinsured patients
  • Prior authorization support: Assistance with appeals and documentation
Note: Patient assistance programs cannot be combined with government insurance programs like Medicare or Medicaid.

Annual Changes: What to Re-Verify

Formulary Status Check

Each January, verify Tavalisse's status on your specific Cigna plan:

  • Tier placement: Specialty medications may move between tiers
  • Prior authorization requirements: May become more or less restrictive
  • Quantity limits: Monthly supply restrictions may change
  • Step therapy: New requirements for trying other medications first

Plan Design Changes

  • Deductible changes: Higher deductibles affect out-of-pocket costs
  • Specialty pharmacy requirements: May need to use specific pharmacies
  • Coverage gaps: "Donut hole" in Medicare Part D plans

Appeals Playbook for Cigna in New Jersey

Internal Appeals Process

First Level Internal Appeal:

  • Deadline: 180 days from denial date
  • Submission: Via Cigna member portal or mail
  • Timeline: 30 days for standard review, 72 hours for expedited
  • Required: Copy of denial letter, additional clinical documentation, prescriber letter

Second Level Internal Appeal:

  • Automatic: If first level is denied
  • Timeline: Additional 30 days for review
  • Reviewer: Different medical professional than first level

New Jersey External Review (IHCAP)

After completing Cigna's internal appeals, New Jersey residents can access the Independent Health Care Appeals Program (IHCAP):

  • Deadline: 180 days from final internal denial
  • Submission: Direct to Maximus Federal Services (contracted by New Jersey)
  • Cost: Free to patients (insurers pay all costs)
  • Timeline: 5 business days for acceptance review, 45 days for final decision
  • Contact: IHCAP hotline at 1-888-393-1062

Required Documentation for Appeals

  • Complete medical records related to ITP diagnosis and treatment
  • All prior authorization requests and denials
  • Prescriber attestation of medical necessity
  • Evidence of treatment failures with alternative therapies
  • Current lab results and clinical assessments

Personal Tracker Template

Renewal Tracking Checklist

Current Authorization Details:

  • Approval date: ___________
  • Expiration date: ___________
  • Authorized quantity: ___________
  • Prescribing physician: ___________

Renewal Timeline:

  • Start date (90 days prior): ___________
  • Documentation gathered: ___________
  • Submission date: ___________
  • Decision received: ___________
  • New expiration date: ___________

Clinical Monitoring:

  • Last platelet count: ___________ (Date: ___________)
  • Last CBC: ___________ (Date: ___________)
  • Last LFTs: ___________ (Date: ___________)
  • Adverse events: ___________
  • Dose changes: ___________

Counterforce Health helps patients and clinicians navigate complex prior authorization and appeals processes by turning insurance denials into targeted, evidence-backed appeals. The platform analyzes denial letters and plan policies to create point-by-point rebuttals aligned with payer requirements, potentially saving weeks of back-and-forth communication.

FAQ

How long does Cigna prior authorization take for Tavalisse in New Jersey? Standard prior authorization reviews take up to 15 business days. Expedited reviews for urgent cases are completed within 72 hours.

What if Tavalisse becomes non-formulary on my Cigna plan? You can request a formulary exception with clinical justification from your prescriber. If denied, the appeals process and external review through IHCAP remain available.

Can I request an expedited appeal in New Jersey? Yes, both Cigna internal appeals and New Jersey external reviews offer expedited timelines when delays would cause serious harm to your health.

Does step therapy apply if I previously failed treatments outside New Jersey? Treatment failures documented by any licensed physician should be accepted, but ensure all documentation is transferred to your current New Jersey provider.

What happens if my Cigna plan changes during treatment? Contact Cigna member services immediately to understand new coverage requirements. You may need a new prior authorization under different plan rules.

How much does Tavalisse cost with Cigna coverage? As a specialty medication, Tavalisse typically falls under Tier 4 or 5 with higher copays. Exact costs depend on your specific plan design and deductible status.

Can my doctor request a peer-to-peer review with Cigna? Yes, prescribers can request to speak directly with Cigna's medical director to discuss the clinical necessity of Tavalisse treatment.

What if I move out of New Jersey during treatment? External review rights will transfer to your new state's program. Contact your new state's insurance department for specific procedures and timelines.

For complex cases requiring detailed appeals strategy, Counterforce Health specializes in turning insurance denials into successful approvals by identifying specific denial reasons and crafting evidence-backed responses that align with each payer's unique requirements.

Sources & Further Reading

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider and insurance company for specific coverage decisions and treatment recommendations. Coverage policies and appeal procedures may change; verify current requirements with official sources.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.